Children's Hospital Los Angeles

This study is testing if a standard immunotherapy drug for high-risk neuroblastoma, a serious childhood cancer, can be safely given over a much shorter time. Currently, the drug (dinutuximab) is infused over 10-20 hours for several days, requiring a hospital stay. Researchers wan…

This study is testing a program called Bright IDEAS, which teaches problem-solving skills to parents of children receiving palliative care. The goal is to see if this training is helpful and acceptable for parents, and if it can reduce their psychological distress compared to sta…